SEC FORM 4
$65,565.20
MADRIGAL PHARMACEUTICALS, INC. (MDGL)
Sale of 120 shares at $546.3767 per share.
Reporting Person Sibold William John · Officer Title President and CEO · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001628280-26-061581 · filed 2026-09-11 · View filing →